Redirecting to https://www.globenewswire.com/news-release/2025/09/09/3146827/0/en/Arrivent-Presents-the-Final-Analysis-of-Firmonertinib-Monotherapy-Data-from-Global-Phase-1b-Study-in-EGFR-PACC-Mutant-Non-Small-Cell-Lung-Cancer-at-the-2025-World-Conference-on-Lun.html